Panacea Life Sciences Holdings, Inc. (PLSH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Older than the company's other figures. The latest EBITDA is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2023-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$2.03M
Year ended 2018-12-31
2014-12-31: -$418.5K2015-12-31: -$387.7K2016-12-31: -$1.60M2017-12-31: -$3.07M2018-12-31: -$2.03M-$2.03M
2014-12-31 EBITDA (USD) 2018-12-31
Period endedEBITDAChange YoYSource filing
2018-12-31-$2.03Mn/m2020-05-22, From 2018-01-01
2017-12-31-$3.07Mn/m2019-03-29, From 2017-01-01
2016-12-31-$1.60Mn/m2018-04-02, From 2016-01-01
2015-12-31-$387.7Kn/m2017-03-31, From 2015-01-01
2014-12-31-$418.5Kn/a2016-02-29, From 2014-01-01